Relay Therapeutics Inc (RLAY)

SG&A Expense Growth

33.23%

Quarterly · Period ending:

RLAY logo

RLAY SG&A Expense Growth

Latest reported33.23%
RLAY Quarterly SG&A Growth (QoQ) (0.00% → 33.23%)
High-resolution chart · PNG

RLAY sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Relay Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
33.2275%
-14.9348%
3.6874%
-9.0896%
-26.6129%
-8.8215%
4.0608%
-1.9316%
1.7173%
-2.9318%
10.3435%
-8.1262%
2.7632%
-0.72%
22.6888%
-7.9645%
8.6943%
3.8387%
-0.1742%
7.4816%
13.247%
-16.9763%
25.4108%
102.0651%
27.2173%
38.8792%
-6.1884%
4.1049%
14.3789%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.